94.55

0.41% -0.39

Globus Medical Inc (GMED)

Overview News Price History Option Chain Financials Discussions Forecast

Globus Medical Inc stock is traded at $94.55, with a volume of 1.04M. It is down -0.41% in the last 24 hours and up +11.54% over the past month. Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

Previous Close:

$94.94

Open:

$95.02

24h Volume:

1.04M

Relative Volume:

0.89

Market Cap:

$12.79B

Revenue:

$2.94B

Net Income/Loss:

$537.87M

P/E Ratio:

24.03

EPS:

3.9341

Net Cash Flow:

$579.02M

1W Performance:

+2.82%

1M Performance:

+11.54%

6M Performance:

+62.09%

1Y Performance:

+30.68%

1-Day Range:

$93.69

$95.98

1-Week Range:

$89.47

$96.04

52-Week Range:

$51.79

$101.40

Globus Medical Inc Stock (GMED) Company Profile

Name

Globus Medical Inc

Sector

Healthcare (1112)

Industry

Medical Devices (143)

Phone

610-930-1800

Address

2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA

Employee

6,000

Twitter

@GlobusMedical

Next Earnings Date

2026-02-24

Latest SEC Filings

GMED's Discussions on Twitter

Compare GMED vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
GMED Globus Medical Inc	94.55	12.84B	2.94B	537.87M	579.02M	3.9341
ABT Abbott Laboratories	101.56	175.59B	44.33B	6.50B	7.40B	3.717
SYK Stryker Corp	341.24	132.47B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	87.10	113.14B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	64.61	94.85B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	78.20	45.09B	6.07B	1.06B	1.34B	1.8063

Globus Medical Inc Stock (GMED) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-30-26	Upgrade	Needham	Hold → Buy
Jan-27-26	Initiated	TD Cowen	Buy
Nov-07-25	Upgrade	BofA Securities	Neutral → Buy
Nov-07-25	Upgrade	Truist	Hold → Buy
Oct-28-25	Resumed	Stifel	Hold
May-27-25	Downgrade	BTIG Research	Buy → Neutral
Jan-10-25	Upgrade	BofA Securities	Underperform → Neutral
Dec-02-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Aug-07-24	Upgrade	Wells Fargo	Equal Weight → Overweight
May-20-24	Upgrade	Piper Sandler	Neutral → Overweight
Mar-18-24	Upgrade	BTIG Research	Neutral → Buy
Oct-20-23	Initiated	ROTH MKM	Buy
Sep-19-23	Upgrade	Stifel	Hold → Buy
Mar-30-23	Upgrade	Canaccord Genuity	Hold → Buy
Feb-13-23	Downgrade	BofA Securities	Buy → Underperform
Feb-10-23	Downgrade	BTIG Research	Buy → Neutral
Feb-10-23	Downgrade	Loop Capital	Buy → Hold
Feb-10-23	Downgrade	Needham	Buy → Hold
Feb-10-23	Downgrade	Truist	Buy → Hold
Feb-10-23	Downgrade	Wells Fargo	Overweight → Equal Weight
Oct-18-22	Initiated	Barclays	Overweight
Oct-12-22	Initiated	Jefferies	Buy
Apr-13-22	Resumed	Truist	Buy
Mar-28-22	Initiated	Wells Fargo	Overweight
Jan-04-22	Upgrade	Piper Sandler	Neutral → Overweight
Dec-13-21	Upgrade	BofA Securities	Underperform → Buy
Dec-10-21	Initiated	RBC Capital Mkts	Outperform
Oct-29-21	Initiated	Loop Capital	Buy
Feb-18-21	Resumed	Needham	Buy
Dec-08-20	Initiated	Citigroup	Buy
Oct-20-20	Initiated	Stifel	Hold
Aug-06-20	Reiterated	Needham	Buy
Aug-06-20	Upgrade	Northland Capital	Market Perform → Outperform
Jul-21-20	Initiated	Northland Capital	Market Perform
Jul-06-20	Downgrade	Piper Sandler	Overweight → Neutral
May-08-20	Reiterated	Needham	Buy
Mar-18-20	Upgrade	BTIG Research	Neutral → Buy
Jan-08-20	Initiated	SunTrust	Buy
Dec-12-19	Upgrade	Wells Fargo	Market Perform → Outperform
Aug-02-19	Reiterated	Needham	Buy
May-24-19	Downgrade	Wells Fargo	Outperform → Market Perform
May-03-19	Reiterated	Needham	Buy
Feb-28-19	Upgrade	UBS	Neutral → Buy
Jan-02-19	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Aug-02-18	Reiterated	Needham	Buy
Jun-27-18	Downgrade	BofA/Merrill	Neutral → Underperform
Jun-01-18	Initiated	Cantor Fitzgerald	Overweight
May-03-18	Reiterated	Needham	Buy
Apr-04-18	Upgrade	Needham	Hold → Buy

View All

Globus Medical Inc Stock (GMED) Latest News

Apr 15, 2026

Wells Fargo initiates coverage of Globus Medical (GMED) with an overweight rating - MSN

Apr 15, 2026

Globus medical outlines $2.8B-$2.9B 2025 revenue guidance amid Nevro integration - MSN

Apr 15, 2026

2 Reasons to Like GMED and 1 to Stay Skeptical - TradingView — Track All Markets

Apr 15, 2026

Apr 14, 2026

[144] GLOBUS MEDICAL INC SEC Filing - Stock Titan

Apr 14, 2026

Globus Medical Receives $104.36 Average Target Price from Analysts - National Today

Apr 14, 2026

Apr 13, 2026

Will Analyst Upgrades and Earnings Revisions Change Globus Medical's (GMED) Narrative? - Sahm

Apr 13, 2026

Rep. Gilbert Ray Cisneros, Jr. Buys Globus Medical, Inc. Shares - National Today

Apr 11, 2026

Apr 10, 2026

Globus Medical, Inc. Class A Common Stock (NY: GMED - The Chronicle-Journal

Apr 10, 2026

How Investors Are Reacting To Globus Medical (GMED) Zacks Rank Upgrade On Higher Earnings Estimates - Yahoo Finance

Apr 10, 2026

Is This the Right Time to Add Globus Medical Stock to Your Portfolio? - Yahoo Finance

Apr 10, 2026

Is It Too Late To Consider Globus Medical (GMED) After Its Strong Share Price Run? - Sahm

Apr 10, 2026

Apr 09, 2026

Is Now a Good Opportunity to Include Globus Medical Shares in Your Investment Portfolio? - Bitget

Apr 09, 2026

Humana Bets on Pharmacists to Lift Chronic Care Outcomes - TradingView

Apr 09, 2026